Pilot trial to compare 24 hour antibiotic regimen with standard 7 day antibiotic regimen for prophylaxis in renal transplant recipients.
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: N185- Chronic kidney disease, stage 5
- Registration Number
- CTRI/2020/07/026868
- Lead Sponsor
- All India Institute Of Medical Sciences New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All Renal transplant recipients except those with cadaveric renal grafts.
2.Patient is able to follow instructions
3.Patients are ready for regular follow up
4.Able to provide informed written consent
Exclusion Criteria
1. Cadaveric renal grafts.
2. Non-compliance with medical care or follow up.
3. Patient suffering from psychiatry problems.
4. Unable to give consent or patient refusal.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms drive bacterial resistance in renal transplant recipients with N185 undergoing short-term vs standard antibiotic prophylaxis?
How does 24-hour vs 7-day prophylactic antibiotic regimens impact post-transplant infection rates and graft survival in CKD stage 5 patients?
Which immune-related biomarkers correlate with efficacy of 24-hour antibiotic prophylaxis in renal transplant recipients with N185?
What nephrotoxicity risks and management strategies are associated with 7-day antibiotic regimens in CKD stage 5 renal transplant patients?
Are combination therapies or alternative antibiotics (e.g., beta-lactams, fluoroquinolones) being evaluated for prophylaxis in renal transplant recipients compared to standard regimens?